99 related articles for article (PubMed ID: 4067853)
21. Allopurinol and lodoxamide in complement-induced hepatic ischemia.
Schirmer WJ; Schirmer JM; Naff GB; Fry DE
J Surg Res; 1988 Jul; 45(1):28-36. PubMed ID: 3260642
[TBL] [Abstract][Full Text] [Related]
22. [Alomide, a preventive immunopharmaceutical agent, in the treatment of ocular atopy].
Krásný J
Cesk Slov Oftalmol; 1998 Jan; 54(1):41-5. PubMed ID: 9501643
[TBL] [Abstract][Full Text] [Related]
23. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials.
Spector SL; Kinsman R; Mawhinney H; Siegel SC; Rachelefsky GS; Katz RM; Rohr AS
J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):65-70. PubMed ID: 3511127
[TBL] [Abstract][Full Text] [Related]
24. Lodoxamide treatment of allergic conjunctivitis.
Cerqueti PM; Ricca V; Tosca MA; Buscaglia S; Ciprandi G
Int Arch Allergy Immunol; 1994 Oct; 105(2):185-9. PubMed ID: 7920019
[TBL] [Abstract][Full Text] [Related]
25. Acute pulmonary response to cotton bract extract in monkeys: lung function and effects of mediator modifying compounds.
Witek TJ; Gundel RH; Wegner CD; Schachter EN; Buck MG
Lung; 1988; 166(1):25-31. PubMed ID: 2891880
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
Oguz H; Bitiren M; Aslan OS; Ozardali I
Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
[TBL] [Abstract][Full Text] [Related]
27. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
Denis D; Bloch-Michel E; Verin P; Sebastiani A; Tazartes M; Helleboid L; Di Giovanni A; Lecorvec M
Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
[TBL] [Abstract][Full Text] [Related]
28. Contact lens induced conjunctivitis: a model of human ocular inflammation.
Friedlaender MH
CLAO J; 1996 Jul; 22(3):205-8. PubMed ID: 8828938
[TBL] [Abstract][Full Text] [Related]
29. A critical look at ocular allergy drugs.
Joseph Titi M
Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
[TBL] [Abstract][Full Text] [Related]
30. Mast cell degranulation and glucose homeostasis.
Nutr Rev; 1987 May; 45(5):152-3. PubMed ID: 3601255
[No Abstract] [Full Text] [Related]
31. Lodoxamide in vernal keratoconjunctivitis.
Lee S; Allard TR
Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
[TBL] [Abstract][Full Text] [Related]
32. The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35.
MacKenzie AE; Caltabiano G; Kent TC; Jenkins L; McCallum JE; Hudson BD; Nicklin SA; Fawcett L; Markwick R; Charlton SJ; Milligan G
Mol Pharmacol; 2014 Jan; 85(1):91-104. PubMed ID: 24113750
[TBL] [Abstract][Full Text] [Related]
33. Contrast of the effect of alomide and sodium cromoglycate in the treatment of allergic eye diseases.
Zhang W; Lin Z
Yan Ke Xue Bao; 2000 Sep; 16(3):214-6. PubMed ID: 12579651
[TBL] [Abstract][Full Text] [Related]
34. Test for reproducibility of metered-dose aerosol valves for pharmaceutical solutions.
Cutie A; Burger J; Clawans C; Dolinsky D; Feinstein W; Gupta B; Grueneberg A; Sciarra J
J Pharm Sci; 1981 Sep; 70(9):1085-7. PubMed ID: 6101162
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the adverse reaction to diethylcarbamazine in Dirofilaria immitis-infected dogs by lodoxamide ethyl.
Desowitz RS; Palumbo NE; Perri SF; Sylvester MS
Am J Trop Med Hyg; 1982 Mar; 31(2):309-12. PubMed ID: 7072895
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of lodoxamide on eosinophil activation.
Capron M; Loiseau S; Papin JP; Robertson S; Capron A
Int Arch Allergy Immunol; 1998 Jun; 116(2):140-6. PubMed ID: 9652307
[TBL] [Abstract][Full Text] [Related]
37. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
Maĭchuk IuF; Khaitova KN; Grishakova MB
Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
[TBL] [Abstract][Full Text] [Related]
38. Acute reoxygenation injury in the isolated rat heart: role of resident cardiac mast cells.
Keller AM; Clancy RM; Barr ML; Marboe CC; Cannon PJ
Circ Res; 1988 Dec; 63(6):1044-52. PubMed ID: 2848639
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
Rodriguez-Garcia A; Macias-Rodriguez Y; Gonzalez-Gonzalez JM
Int Ophthalmol; 2018 Jun; 38(3):1243-1249. PubMed ID: 28602013
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
Gündüz K; Uçakhan O; Budak K; Eryilmaz T; Ozkan M
Ophthalmic Res; 1996; 28(2):80-7. PubMed ID: 8792357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
